Sibutramine warning

January 28th, 2010  |  Published in Stumpblog  |  5 Comments

From JAMA:

Preliminary data suggest that taking the weight loss drug sibutramine (aka Meridia in the US or Reductil in the UK) may increase a patient’s risk of adverse cardiovascular events such as heart attack and/or stroke, according to the US Food and Drug Administration (FDA).

After reviewing the study, the FDA asked the manufacturer to add a warning to the label. The manufacturer, Knoll Pharmaceutical Company, has agreed to add the warning.

Responses

  1. Lieke says:

    January 28th, 2010at 9:36 am(#)

    I used the drug for a few months (without a doctor’s prescription), some years ago: I was lucky I’d done my homework and that I knew one of the other potentially harmful side effects was depression. A short time after discontinuing the drug, I felt fine again. In any case, the weight loss was minimal, the side effects (severe, “no sense in living any more” depression effects) really awful.

  2. GrĂ¡inne says:

    January 30th, 2010at 4:00 am(#)

    It’s been withdrawn from the market in Europe because of the potential cardiac side effects. One of the people I work with came to me the day it happened all upset because she thought her last chance had evaporated! Had to break it to her that it didn’t work particularly well in the first place…. Scary the stuff we’ll take to look better.

  3. Justin_P says:

    February 3rd, 2010at 10:13 pm(#)

    Justin_P Warning…

    Every weight loss drug ever made, or yet-to-be-made, is dangerous for your health, somehow, someway.

    Eat right, hit the gym, and stop being lazy.

  4. Emily says:

    February 22nd, 2010at 2:40 pm(#)

    Krista? Are you coming back? Just busy lately?

  5. Siobhan says:

    March 7th, 2010at 8:06 pm(#)

    Hey Krista,
    Love your blog and miss your updates. Hope you post again soon!


Get "Fuck Calories"

Enter your information below and the magical gnomes that run Stumptuous will send you a copy of the "Fuck Calories" e-book for free!
Name:
Email Marketing by Javelin

Share